Bumper Offer - Urjas oil Just @ Rs. 1
Betakon is a prescription drug, available for use as Tablet. It is typically used for the treatment of Angina, High BP. Other than this, Betakon has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Betakon is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Betakon also has some side effects, the most common being Fainting. Some other side effects of Betakon have been listed ahead. Usually, these side effects of Betakon go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Betakon's effect during pregnancy is Severe and Mild while nursing. Further, the section on Betakon related warnings talks about Betakon's effects on the liver, heart and kidney.
Betakon can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Betakon in conditions like Asthma, Diabetes, Liver Disease. The section on Betakon contraindications lists all such conditions.
Drug interactions for Betakon have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Betakon is not safe while driving, and is is not addictive in nature.
Betakon is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Betakon is used -
Severe
Moderate
Mild
Common
Is the use of Betakon safe for pregnant women?
Betakon has many dangerous side effects in pregnant women. If you are pregnant, do not consume Betakon without medical advice.
Is the use of Betakon safe during breastfeeding?
Side effects of Betakon on breastfeeding women are very mild.
What is the effect of Betakon on the Kidneys?
Using Betakon does not have any harmful effects on kidneys.
What is the effect of Betakon on the Liver?
Betakon is rarely harmful for the liver.
What is the effect of Betakon on the Heart?
Side effects of Betakon rarely affect the heart.
Betakon should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Betakon unless your doctor advises you to do so -
Is this Betakon habit forming or addictive?
No, there is no any evidence that Betakon is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Betakon can make you feel drowsy.
Is it safe?
Betakon is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Betakon cannot treat any kind of mental disorder.
Interaction between Food and Betakon
Betakon may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Betakon
Taking Betakon with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Inderal® (propranolol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1059-1062
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 532-533
